SCHEDULE 13G/A
Statement of Beneficial Ownership
Stoke Therapeutics, Inc. Filed Acc 0001104659-26-062573
Loading xslSCHEDULE_13G_X02/primary_doc.xml…
Stoke Therapeutics, Inc. Filed Acc 0001104659-26-062573
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…